Search research articles
Contact Us
Filters
Showing results (61-70 of 252) with videos related to
Page
of 26
Sort By:
Anticancer Research
|
September 10, 2014
Phase I study of Efatutazone, an oral PPARγ agonist, in patients with metastatic solid tumors
Haruyasu Murakami, Akira Ono, Toshiaki Takahashi, et al.
Japanese Journal of Clinical Oncology
|
July 27, 2010
Weekly Paclitaxel after failure of gemcitabine in pancreatic cancer patients with malignant ascites: a retrospective study
Takehito Shukuya, Hirofumi Yasui, Narikazu Boku, et al.
World Journal of Surgery
|
December 14, 2019
The Safety and Survival Outcome of Hepatectomy with Combined Bile Duct Resection for Colorectal Liver Metastasis
Takaaki Ito, Teiichi Sugiura, Yukiyasu Okamura, et al.
Brain Tumor Pathology
|
February 24, 2011
Detection of IDH1 mutation in human gliomas: comparison of immunohistochemistry and sequencing
Shingo Takano, Wei Tian, Masahide Matsuda, et al.
Japanese Journal of Clinical Oncology
|
July 7, 2010
Phase I study of docetaxel, cisplatin and S-1 in patients with advanced gastric cancer
Shuichi Hironaka, Kentaro Yamazaki, Keisei Taku, et al.
Japanese Journal of Clinical Oncology
|
May 1, 2009
Retrospective analysis of S-1 monotherapy in patients with metastatic colorectal cancer after failure to fluoropyrimidine and irinotecan or to fluoropyrimidine, irinotecan and oxaliplatin
Hirofumi Yasui, Takayuki Yoshino, Narikazu Boku, et al.
Cancer Chemotherapy and Pharmacology
|
May 4, 2023
Phase I study of the VEGF/Ang-2 inhibitor BI 836880 alone or combined with the anti-programmed cell death protein-1 antibody ezabenlimab in Japanese patients with advanced solid tumors
Noboru Yamamoto, Takafumi Koyama, Toshio Shimizu, et al.
Cancer Chemotherapy and Pharmacology
|
July 26, 2014
Phase I dose-escalation study of the HSP90 inhibitor AUY922 in Japanese patients with advanced solid tumors
Toshihiko Doi, Yusuke Onozawa, Nozomu Fuse, et al.
Investigational New Drugs
|
December 17, 2013
Phase 1 study of efatutazone, a novel oral peroxisome proliferator-activated receptor gamma agonist, in combination with FOLFIRI as second-line therapy in patients with metastatic colorectal cancer
Yoshito Komatsu, Takayuki Yoshino, Kentaro Yamazaki, et al.
BMC Cancer
|
January 20, 2023
Biomarker analysis for patients with pancreatic cancer treated with nanoliposomal irinotecan plus 5-fluorouracil/leucovorin
Takeshi Kawakami, Akiko Todaka, Kotoe Oshima, et al.
Page
of 26
Search research articles
Search
Showing results (61-70 of 252) with videos related to
Sort By:
Page
of 26
Anticancer Research
|
September 10, 2014
Phase I study of Efatutazone, an oral PPARγ agonist, in patients with metastatic solid tumors
Haruyasu Murakami, Akira Ono, Toshiaki Takahashi, et al.
Japanese Journal of Clinical Oncology
|
July 27, 2010
Weekly Paclitaxel after failure of gemcitabine in pancreatic cancer patients with malignant ascites: a retrospective study
Takehito Shukuya, Hirofumi Yasui, Narikazu Boku, et al.
World Journal of Surgery
|
December 14, 2019
The Safety and Survival Outcome of Hepatectomy with Combined Bile Duct Resection for Colorectal Liver Metastasis
Takaaki Ito, Teiichi Sugiura, Yukiyasu Okamura, et al.
Brain Tumor Pathology
|
February 24, 2011
Detection of IDH1 mutation in human gliomas: comparison of immunohistochemistry and sequencing
Shingo Takano, Wei Tian, Masahide Matsuda, et al.
Japanese Journal of Clinical Oncology
|
July 7, 2010
Phase I study of docetaxel, cisplatin and S-1 in patients with advanced gastric cancer
Shuichi Hironaka, Kentaro Yamazaki, Keisei Taku, et al.
Japanese Journal of Clinical Oncology
|
May 1, 2009
Retrospective analysis of S-1 monotherapy in patients with metastatic colorectal cancer after failure to fluoropyrimidine and irinotecan or to fluoropyrimidine, irinotecan and oxaliplatin
Hirofumi Yasui, Takayuki Yoshino, Narikazu Boku, et al.
Cancer Chemotherapy and Pharmacology
|
May 4, 2023
Phase I study of the VEGF/Ang-2 inhibitor BI 836880 alone or combined with the anti-programmed cell death protein-1 antibody ezabenlimab in Japanese patients with advanced solid tumors
Noboru Yamamoto, Takafumi Koyama, Toshio Shimizu, et al.
Cancer Chemotherapy and Pharmacology
|
July 26, 2014
Phase I dose-escalation study of the HSP90 inhibitor AUY922 in Japanese patients with advanced solid tumors
Toshihiko Doi, Yusuke Onozawa, Nozomu Fuse, et al.
Investigational New Drugs
|
December 17, 2013
Phase 1 study of efatutazone, a novel oral peroxisome proliferator-activated receptor gamma agonist, in combination with FOLFIRI as second-line therapy in patients with metastatic colorectal cancer
Yoshito Komatsu, Takayuki Yoshino, Kentaro Yamazaki, et al.
BMC Cancer
|
January 20, 2023
Biomarker analysis for patients with pancreatic cancer treated with nanoliposomal irinotecan plus 5-fluorouracil/leucovorin
Takeshi Kawakami, Akiko Todaka, Kotoe Oshima, et al.
Page
of 26